ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5820.01M
Enterprise Value 3639.55M
Trailing P/E N/A
Forward P/E 1-3.09
PEG Ratio (5 yr expected) 1-0.10
Price/Sales (ttm)N/A
Price/Book (mrq)5.20
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.89

Trading Information

Stock Price History

Beta (3Y Monthly) 3.02
52-Week Change 3-45.35%
S&P500 52-Week Change 36.70%
52 Week High 320.87
52 Week Low 39.44
50-Day Moving Average 311.37
200-Day Moving Average 312.38

Share Statistics

Avg Vol (3 month) 3969.25k
Avg Vol (10 day) 3925.78k
Shares Outstanding 567.84M
Float 69.78M
% Held by Insiders 15.20%
% Held by Institutions 1101.40%
Shares Short (Jun 28, 2019) 415.4M
Short Ratio (Jun 28, 2019) 416.27
Short % of Float (Jun 28, 2019) 424.95%
Short % of Shares Outstanding (Jun 28, 2019) 418.45%
Shares Short (prior month May 31, 2019) 413.52M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.21%
Return on Equity (ttm)-99.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-161.99M
EBITDA -337.77M
Net Income Avi to Common (ttm)-333.6M
Diluted EPS (ttm)-4.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)474.62M
Total Cash Per Share (mrq)5.68
Total Debt (mrq)190.41M
Total Debt/Equity (mrq)73.01
Current Ratio (mrq)8.34
Book Value Per Share (mrq)1.89

Cash Flow Statement

Operating Cash Flow (ttm)-251.33M
Levered Free Cash Flow (ttm)-171.95M